3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
12
Prostatic Neoplasms
11
Oropharyngeal Neoplasms
10
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Breast Neoplasms
9
Glioma
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
6
Neoplasm Metastasis
5
Mouth Neoplasms
5
Carcinoma
5
Burkitt Lymphoma
5
Astrocytoma
5
Sarcoma
4
Pancreatic Neoplasms
4
Laryngeal Neoplasms
4
Gliosarcoma
4
Carcinoma, Hepatocellular
4
Brain Neoplasms
4
Adenocarcinoma of Lung
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Rectal Neoplasms
3
Neoplasms
3
Interventions
Cyclophosphamide
5
Etoposide
3
duvelisib
2
Vincristine
2
Prednisone
2
Melphalan
2
Doxorubicin
2
Azacitidine
2
10-propargyl-10-deazaaminopterin
2
tazemetostat
1
sodium-iodide symporter
1
ruxolitinib
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
etoposide phosphate
1
cemiplimab
1
belinostat
1
X-Rays
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Prednisolone
1
Photons
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Mycophenolic Acid
1
Methotrexate
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoblastic Lymphadenopathy
×
Radiation
×
90 days
×
Clear all
No trials found.